CDER Vs. CBER: Consulting As Usual, Or Hints Of Inter-Center Power Struggle?

In the Provenge review documents FDA has released so far, there is little indication of overt struggle between the drugs and biologics camps - but many signs that the overheated public and media atmosphere was making the agency especially careful in its dealings with the sponsor.